HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sex difference in adrenal developmental toxicity induced by dexamethasone and its intrauterine programming mechanism.

Abstract
Dexamethasone is widely used to treat preterm labor and related diseases. However, prenatal dexamethasone treatment (PDT) can cause multiorgan developmental toxicities in offspring. Our previous study found that the occurrence of fetal-originated diseases was associated with adrenal developmental programming alterations in offspring. Here, we investigated the effects of PDT on adrenal function in offspring and its intrauterine programming mechanism. A rat model of PDT was established to observe the alterations of adrenal steroidogenesis in offspring. Furthermore, we confirmed the sex differences of adrenal steroidogenesis and its molecular mechanism combined with in vivo and in vitro experiments. PDT caused a decrease in adrenal steroidogenic function in fetal rats, but it was decreased in males and increased in females after birth. Meanwhile, the adrenal H3K14ac level and expression of 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) in PDT offspring were decreased in males and increased in females, suggesting that 11β-HSD2 might mediate sex differences in adrenal function. We further confirmed that dexamethasone inhibited the H3K14ac level and expression of 11β-HSD2 through the GR/SP1/p300 pathway. After bilateral testectomy or ovariectomy of adult PDT offspring rats, adrenal 11β-HSD2 expression and steroidogenic function were both reduced. Using rat primary fetal adrenal cells, the differential expression of AR and ERβ was proven to be involved in regulating the sex difference in 11β-HSD2 expression. This study demonstrated the sex difference in adrenal steroidogenic function of PDT offspring after birth and elucidated a sex hormone receptor-dependent epigenetically regulating mechanism for adrenal 11β-HSD2 programming alteration.
AuthorsYawen Chen, Dan Xu, Xuan Xia, Guanghui Chen, Hao Xiao, Liaobin Chen, Hui Wang
JournalPharmacological research (Pharmacol Res) Vol. 174 Pg. 105942 (12 2021) ISSN: 1096-1186 [Electronic] Netherlands
PMID34656764 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Elsevier Ltd. All rights reserved.
Chemical References
  • Glucocorticoids
  • Receptors, Steroid
  • Dexamethasone
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 (metabolism)
  • Adrenal Glands (drug effects, metabolism)
  • Animals
  • Dexamethasone (toxicity)
  • Female
  • Fetal Development (drug effects)
  • Glucocorticoids (toxicity)
  • Male
  • Maternal-Fetal Exchange
  • Pregnancy
  • Rats, Wistar
  • Receptors, Steroid (genetics, metabolism)
  • Sex Characteristics
  • Uterus
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: